ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

ACCC Members Find Few Answers, Many Problems

February 7, 1975

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

August 13, 2004

ACCC Manual Tells How To Set Up, Run Cancer Program

August 27, 1976

NCI Cooperative Group Clinical Trials Approved

April 30, 2010

More money would speed progress, NCI says, but backs off previous commitment to meet 2015 goal by 2010.

July 29, 2005

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989